The Neuro-Bio website is currently under review and will be updated very shortly so please return soon for more information.
Baroness Professor Susan Greenfield Chief Scientific Officer and Founder
Baroness Susan Greenfield CBE, co-founder of Neuro-Bio, conducts research on novel mechanisms of neurodegeneration at the University of Oxford. She has received 30 Honorary Degrees from British and foreign universities. Other awards include Michael Faraday Medal from the Royal Society (1998), Honorary Fellowship of the Royal College of Physicians (2000), L'Ordre National de la Légion d'Honneur (2003), American Academy of Achievement Golden Plate Award (2003), Honorary Fellowship of the Royal Society of Edinburgh (2007) and Australian Medical Research Society Medal (2010). To find out more go to www.susangreenfield.com.
To contact Susan email: Susan.Greenfield@neuro-bio.com
Charles Morgan Chairman and Non-Executive Director
Dr Morgan has successfully identified emerging international opportunities and is strategically positioned in a wide range of ventures around the globe. His particular strengths include partnering with regional and technology experts, securing teams of appropriate executives and to develop businesses. Mr Morgan has extensive experience in equity capital markets and has been involved with numerous projects over a 20 year period.
Dr Linda E Cammish, MBA Board Adviser
Dr Cammish has over 25 years experience in the life science sector in businesses offering products and services including reagents, hardware, software and drug discovery services and technology access programmes, selling into the academic, pharmaceutical and biotechnology markets. Her background includes extensive experience in senior general management, business development, sales and marketing roles in companies including Millipore, PerSeptive Biosystems, Applied Biosystems and Abcam. More recently she was CEO at nanoTherics raising significant investment for the company, establishing a company infrastructure and growing revenues with double digit sales growth year on year. She holds a Ph.D. from the University of Cambridge and an MBA from Henley Management College.
To contact Linda email: firstname.lastname@example.org
Dr Sara Garcia Ratés Senior Neurobiologist
Dr Garcia Ratés has a PhD in Research, Development and Drug Control from the University of Barcelona with her thesis "Interaction of the amphetamine derivates with the nicotinic receptors: Molecular and functional aspects". Her interest in non-traditional properties of the nicotinic receptor attracted her to a position at the Department of Pharmacology, Oxford University as a Postdoctoral Researcher with Baroness Greenfield, exploring novel approaches to neurodegeneration. This group has published extensively on non-traditional actions of acetylcholinesterase (AchE) focusing on a novel theory on non-traditional actions of an 'AChE-peptide' and the interaction with an alternative or allosteric site of the α7-nAChR. Sara's project was concerned with a therapeutic strategy to characterise binding of the peptide to the receptor site to arrest further cell loss and intercept its further action to find a possible novel and effective candidate to cure Alzheimer's and other neurodegenerative diseases.
To contact Sara email: Sara.GarciaRates@neuro-bio.com
Mr Scott Badin Pharmacologist
Scott Badin holds a BSc (H) in Biological Sciences (Pharmacology) from The University of Edinburgh, and is now finishing a PhD in neuropharmacology at The University of Oxford. He is the pharmacologist expert of the group and focuses his research on use of electrophysiology and voltage-sensitive dye imaging (VSDI) in order to monitor cortical activity at the meso-scale of brain organisation at physiologically-relevant spatio-temporal resolution (of millisecond and micrometers). Mr. Badin's first publication investigated the acute bioactivity of acetylcholine esterase-related peptides on in vitro cortical networks and validated the use of such on-line recording techniques as an adequate screening tool for probing the bioactivity and efficacy of drugs.
To contact Scott email: Scott.Badin@neuro-bio.com
Mr Paul Morrill Biochemistry
Mr. Paul Morrill holds a BSc (H) in Biology from The University of Southampton where he specialised in cellular and molecular biology. His primary role is conducting immunological and biochemical investigative research of the Neuro-Bio theory. Mr Morrill is responsible for sample analysis as a proof of concept of the Neuro-Bio theory and its characteristics in development, and moreover the analysis of acetylcholinesterase-related peptide biomarkers in clinical samples. His current projects focus on immuno-detection of peptides using ELISA and Western-blot techniques.
Miss Emily Smith Office Manager and PA to Baroness Greenfield
Emily Smith has had a wide range of experience in the service industry, from catering to leisure organisations: however for the last 18 months she has been personal assistant to Baroness Greenfield dealing with a range of sectors including academia, the media, finance and politics (House of Lords).
To contact Emily email: email@example.com
Professor Robin Murphy Consultant on Behaviour Testing
Professor Robin Murphy at University of Oxford is Experimental Psychologist and Behavioural Neuroscientist who studies learning and memory